• Pear VC
  • How We Invest
    • Overview
    • Our Verticals
    • PearX
    • Seed
    • Why Pear?
  • Founder Services
    • Overview
    • Talent Services
    • Fundraising
    • Go-To-Market Services
  • Programs
    • Overview
    • Dorm
    • Female Founders Circles
    • Persian Founders Circles
  • Resources
    • Featured
    • Events & Summits
    • Blog
    • Press
    • Pear Almanac
    • Pear Healthcare Playbook
  • Companies
  • Team
PearX
PearX
  1. Resources
  2. Blog
  3. Page 5
  • Our investment in Gravis Robotics

    Our investment in Gravis Robotics

    Read More: Our investment in Gravis Robotics

  • Dr. Muthu Alagappan, CEO and Founder of Counsel, on defining a new healthcare paradigm in asynchronous care

    Dr. Muthu Alagappan, CEO and Founder of Counsel, on defining a new healthcare paradigm in asynchronous care


  • Startup sales success requires unlocking the power of mindset: lessons from Jason Ferguson

    Startup sales success requires unlocking the power of mindset: lessons from Jason Ferguson


  • My journey with founder-led sales: lessons from Tracy Young

    My journey with founder-led sales: lessons from Tracy Young


  • Congratulations, BioAge! (NASDAQ: BIOA)

    Congratulations, BioAge! (NASDAQ: BIOA)


  • Introducing the Pear Emerging Managers in Residence 

    Introducing the Pear Emerging Managers in Residence 


  • Zero to $1M: Winning early GTM!

    Zero to $1M: Winning early GTM!


  • Fall Speaker Series

    Fall Speaker Series


  • The Changing Landscape of Data in the AI Era

    The Changing Landscape of Data in the AI Era


  • Navigating Security: Opportunities and Challenges in the AI Era

    Navigating Security: Opportunities and Challenges in the AI Era


  • Human Simulating AI Agents are Closest Approach to AGI, Unlocking Value in our Everyday Lives

    Human Simulating AI Agents are Closest Approach to AGI, Unlocking Value in our Everyday Lives


  • Pear Biotech Bench to Business: insights on ‘Designer Immune Systems,’ allogeneic stem cell therapies, and making an impact on the lives of patients with Ivan Dimov

    Pear Biotech Bench to Business: insights on ‘Designer Immune Systems,’ allogeneic stem cell therapies, and making an impact on the lives of patients with Ivan Dimov


  • PearX W25 applications are now open

    PearX W25 applications are now open

Previous Page
1 … 3 4 5 6 7 … 15
Next Page

San Francisco

600 Townsend Street
San Francisco, CA 94103


Menlo Park

241 El Camino Real
Menlo Park, CA 94025

How We Invest
PearX
Our Verticals
Seed
Why Pear?
Founder Services
Pear Studio
Talent Services
Fundraising
Go-To-Market Services
PR & Marketing
Programs
Dorm
Female Founders Circle
Persian Founder Circle
Resources
Events & Summits
Blog
Press
Pear Almanac
Our Story
Core Values
Contact Us
Media Kit
Companies
Team
How We Invest
Programs
Team
Contact Us
Founder Services
Resources
Companies
Our Story
Pear VC Logo

Notifications